Cited by 1,210Sirtuins and Resveratrol in MedicineGenetics, Aging, and Longevity in Model OrganismsAutophagy in Disease and Therapy

The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling

Open access
Mouchiroud, Laurent, Houtkooper, Riekelt H., Moullan, Norman, Katsyuba, Elena, Ryu, Dongryeol, Cantó, Carles, Mottis, Adrienne, Jo, Young-Suk +4 more·2013·Cell

Abstract

NAD(+) is an important cofactor regulating metabolic homeostasis and a rate-limiting substrate for sirtuin deacylases. We show that NAD(+) levels are reduced in aged mice and Caenorhabditis elegans and that decreasing NAD(+) levels results in a further reduction in worm lifespan. Conversely, genetic or pharmacological restoration of NAD(+) prevents age-associated metabolic decline and promotes longevity in worms. These effects are dependent upon the protein deacetylase sir-2.1 and involve the induction of mitonuclear protein imbalance as well as activation of stress signaling via the mitochondrial unfolded protein response (UPR(mt)) and the nuclear translocation and activation of FOXO transcription factor DAF-16. Our data suggest that augmenting mitochondrial stress signaling through the modulation of NAD(+) levels may be a target to improve mitochondrial function and prevent or treat age-associated decline.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2013.06.016

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A disturbed balance between nuclear DNA-encoded and mtDNA-encoded OXPHOS proteins, independent of mitochondrial content, has previously been associated with activation of mitochondrial quality control mechanisms such as the mtUPR.

    “A disturbed balance between the nuclear DNA-encoded and mitochondrial DNA (mtDNA)-encoded OXPHOS proteins, independent of mitochondrial content, has previously been associated with the activation of mitochondrial quality control mechanisms such as the mtUPR [32, 33].”

    From Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity (2021) · cites this paper as [33]

    The Results (‘Early phase activation of UPRmt by NAD+ boosters’; page unavailable) associate a changed ratio of nuclear- and mtDNA-encoded OXPHOS proteins with UPRmt activation. The cited passages do not establish that this association is independent of mitochondrial content; the mammalian-cell Results also report mitochondrial biogenesis after treatment. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In brain tissues from old normal mice and accelerated aging mice, declining NAD+ contributes to age-associated decline in mitochondrial biogenesis via impaired SIRT1-PGC-1a signaling.

    “In brain tissues from old normal mice and accelerated aging mice, a decline in NAD+ levels contributes to the age-associated decline of mitochondrial biogenesis via impaired SIRT1-PGC-1a signaling (Fang et al., 2014; Mouchiroud et al., 2013; Stein and Imai, 2014).”

    From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Mouchiroud et al., 2013

  • NAD+ is central to mitochondrial homeostasis, including mitochondrial biogenesis, mitophagy, UPRmt, and nuclear-mitochondrial communication.

    “NAD+ is central to mitochondrial homeostasis, including in mitochondrial biogenesis, mitophagy, the mitochondrial unfolded protein response (UPRmt), and nuclear-mitochondrial communication (Fang et al., 2014; Gomes et al., 2013; Mouchiroud et al., 2013).”

    From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Mouchiroud et al., 2013

  • Reduced NAD+ downregulates SIRT1, an NAD+-dependent deacetylase involved in mitochondrial homeostasis and XPA repair activity.

    “They observed that the reduced level of NAD+ downregulated SIRT1, a NAD+- dependent deacetylase involved in regulating mitochondrial homeostasis and XPA repair activity 91–93.”
  • A supraphysiologic dose of NAM (1-5 mM compared with 200 μM used in lifespan extension experiments) has been associated with reduced lifespan in yeast and C. elegans.

    “a supraphysiologic dose of NAM (1–5 mM as compared with 200 μM used in experiments with lifespan extension190) has also been associated with reduced lifespan in yeast and C. elegans190–192.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., Guarente, L., & Auwerx, J.
Affiliations
  • École Polytechnique Fédérale de Lausanne (CH)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Massachusetts Institute of Technology (US)
Corresponding author
Auwerx, Johan
Venue
Cell
Publisher
Elsevier BV
Published
2013-07
Volume
154
Issue
2
Pages
430-441
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2012043504
Cited by
1,210
References
58
Citations by year
2026: 60 · 2025: 90 · 2024: 102 · 2023: 90 · 2022: 116 · 2021: 117 · 2020: 124 · 2019: 103 · 2018: 88 · 2017: 84 · 2016: 91 · 2015: 63 · 2014: 67 · 2013: 12
FWCI
36.13
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
  • Pure Amsterdam UMC (submittedVersion)
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (125487, 124713)
  • ZonMw (91613050)
  • National Institute on Aging (R56AG015339, R01AG043930, R01AG015339)
  • National Heart, Lung, and Blood Institute (R01HL106511)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
NAD+, sirtuins, sir-2.1, longevity, aging, mitochondrial unfolded protein response, FOXO, DAF-16, Caenorhabditis elegans
MeSH terms
Poly(ADP-ribose) Polymerase Inhibitors, Aging, Animals, Longevity, Mitochondria, NAD, Transcription Factors, Signal Transduction, Caenorhabditis elegans, Reactive Oxygen Species, Hepatocytes, Caenorhabditis elegans Proteins, Sirtuins, Mice, Forkhead Transcription Factors, Sirtuin 1, Unfolded Protein Response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review